Revenue (Quarterly) Chart

View Revenue (Quarterly) for MDOMF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 2003. Start Trial.
Date Value
December 31, 2025 116.45M
September 30, 2025 135.80M
June 30, 2025 146.86M
March 31, 2025 125.00M
December 31, 2024 117.81M
September 30, 2024 133.45M
June 30, 2024 123.63M
March 31, 2024 125.01M
December 31, 2023 118.59M
September 30, 2023 129.21M
June 30, 2023 134.19M
March 31, 2023 130.48M
December 31, 2022 121.06M
September 30, 2022 120.02M
June 30, 2022 123.62M
March 31, 2022 126.91M
December 31, 2021 116.85M
September 30, 2021 135.64M
June 30, 2021 131.44M
March 31, 2021 144.89M
December 31, 2020 137.71M
September 30, 2020 152.14M
June 30, 2020 161.82M
March 31, 2020 174.81M
December 31, 2019 168.20M
Date Value
September 30, 2019 209.37M
June 30, 2019 199.83M
March 31, 2019 162.61M
December 31, 2018 152.55M
September 30, 2018 193.48M
June 30, 2018 204.42M
March 31, 2018 167.06M
December 31, 2017 168.72M
September 30, 2017 196.32M
June 30, 2017 202.12M
March 31, 2017 157.79M
December 31, 2016 156.22M
September 30, 2016 207.07M
June 30, 2016 195.80M
March 31, 2016 155.80M
December 31, 2015 125.12M
September 30, 2015 170.64M
June 30, 2015 173.73M
March 31, 2015 137.52M
December 31, 2014 140.55M
September 30, 2014 180.85M
June 30, 2014 192.44M
March 31, 2014 149.78M
December 31, 2013 157.20M
September 30, 2013 192.67M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
Kao Corp. 2.879B
Kosé Holdings Corp. 543.76M
euglena Co., Ltd. 83.52M
Milbon Co., Ltd. 90.76M
Rohto Pharmaceutical Co., Ltd. 574.97M